HbA1c Trends with Treatment Intensification following Inadequate Response to Two Oral Agents in Patients with Type 2 Diabetes

被引：0
|
作者：
Kim, Kibum
Unni, Sudhir
Brixner, Diana
Thomas, Sheila
Olsen, Cody J.
Sterling, Kimberly L.
Mitchell, Matt
Mcadam-Marx, Carrie
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-909-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Treatment Progression and Impact of HbA1C in Type 2 Diabetes (T2DM) Patients
    Dibello, Julia R.
    Levy, Brian
    Mehra, Maneesha
    DIABETES, 2010, 59 : A623 - A624
  • [32] Baseline HbA1c is the major clinical predictor of glycaemic response to incretin based agents in Type 2 diabetes
    Jones, A. G.
    Hill, A. V.
    Stewart, J.
    Githens-Mazer, G.
    Shields, B. M.
    McDonald, T. J.
    Knight, B. A.
    Hattersley, A. T.
    DIABETIC MEDICINE, 2013, 30 : 164 - 164
  • [33] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Jiaqi Hu
    Huichun Hsu
    Xiaodan Yuan
    Kezheng Lou
    Cunyi Hsue
    Joshua D. Miller
    Juming Lu
    Yaujiunn Lee
    Qingqing Lou
    Journal of Endocrinological Investigation, 2021, 44 : 1229 - 1236
  • [34] HbA1c trajectories in type 2 diabetes patients: The Diabetes Care System cohort
    Nijpels, G.
    Walraven, I.
    Mast, M. R.
    Hoekstra, T.
    Jansen, A. P. D.
    van der Heijden, A. A. W.
    Rauh, S. P.
    Rutters, F.
    van 't Riet, E.
    Elders, P. J. M.
    Moll, A. C.
    Polak, B. C. P.
    Dekker, J. M.
    DIABETOLOGIA, 2014, 57 : S114 - S115
  • [35] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Hu, Jiaqi
    Hsu, Huichun
    Yuan, Xiaodan
    Lou, Kezheng
    Hsue, Cunyi
    Miller, Joshua D.
    Lu, Juming
    Lee, Yaujiunn
    Lou, Qingqing
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (06) : 1229 - 1236
  • [36] Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes?
    Michaela Luconi
    Besmir Nreu
    Jinous Samavat
    Maria Lorubbio
    Agostino Ognibene
    Matteo Monami
    Edoardo Mannucci
    Acta Diabetologica, 2016, 53 : 669 - 672
  • [37] Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes?
    Luconi, Michaela
    Nreu, Besmir
    Samavat, Jinous
    Lorubbio, Maria
    Ognibene, Agostino
    Monami, Matteo
    Mannucci, Edoardo
    ACTA DIABETOLOGICA, 2016, 53 (04) : 669 - 672
  • [38] Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents
    Kim, Kibum
    Unni, Sudhir
    McAdam-Marx, Carrie
    Thomas, Sheila M.
    Sterling, Kimberly L.
    Olsen, Cody J.
    Johnstone, Bryan
    Mitchell, Matt
    Brixner, Diana
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (03): : 314 - +
  • [39] Effects of finerenone in patients with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability and duration of diabetes
    McGill, J. B.
    Agarwal, R.
    Anker, S. D.
    Bakris, G. L.
    Filippatos, G.
    Pitt, B.
    Ruilope, L. M.
    Birkenfeld, A. L.
    Caramori, M. L.
    Brinker, M.
    Joseph, A.
    Lage, A.
    Lawatscheck, R.
    Scott, C.
    Rossing, P.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S318 - S318
  • [40] Effect of mean HbA1c on the association of HbA1c variability and all-cause mortality in patients with type 2 diabetes
    Tseng, Juei-Yu
    Chen, Hsin-Hung
    Huang, Kuo-Chin
    Hsu, Sheng-Pang
    Chen, Ching-Chu
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 680 - 687
12345